The interferon-stimulated gene product HERC5 inhibits human LINE-1 retrotransposition with an ISGylation-independent mechanism
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Kei Nishimori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Retrotransposon Dynamics, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan. Hauptthemen laut MEDLINE: Long Interspersed Nucleotide Elements, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RIKEN Junior Research Associate, RIKEN Special Postdoctoral Research programs, JSPS KAKENHI.
Abstract (Originalsprache)
Mobilization of Long INterspersed Element-1 (LINE-1 or L1) compromises genome stability and can cause sporadic genetic diseases. Accordingly, cells have evolved multiple mechanisms to restrict L1 retrotransposition. Several interferon-stimulated genes (ISGs) that interact with cytoplasmic L1 ribonucleoproteins (RNPs), which contain the L1-encoded proteins ORF1p and ORF2p, have been identified as suppressors of L1 retrotransposition. We previously reported that the ISG protein HECT and RLD domain containing E3 ubiquitin-protein ligase 5 (HERC5) efficiently inhibits L1 retrotransposition. While HERC5 is known to restrict numerous viruses through ISGylation, how HERC5 inhibits L1 remains to be elucidated. Here, we show that HERC5 inhibits L1 retrotransposition through an ISGylation-independent mechanism. HERC5 interacts with L1 RNA and selectively reduces ORF1p levels in a manner that requires the full-length ORF1p expression. We further demonstrate that HERC5 decreases L1 translation efficiency and alters L1 RNP composition. Our comparative analysis further suggests that HERC5 may have acquired its L1-inhibitory function during the evolution of the small HERC family. These findings uncover a previously unidentified mechanism by which an ISG protein associates with and inhibits L1 and suggest a role for HERC5 as an evolutionarily adapted restriction factor that expands the repertoire of cellular defenses against retrotransposons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Retrotransposon Dynamics, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
- Department of Gene Mechanisms, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
- Proteomics Facility, Graduate School of Biostudies, Kyoto University, Kyoto 606-8502, Japan.
- Laboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
- Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8510, Japan.
ORCID-Profile: Kei Nishimori, Takuhiro Ito, Tomoichiro Miyoshi
Förderung
- RIKEN Junior Research Associate
- RIKEN Special Postdoctoral Research programs
- JSPS KAKENHI
- JST PRESTO
- Takeda Science Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Nagase Science Technology Foundation
- AMED
Zitieren
APA
Nishimori, K., Luqman-Fatah, A., Watanabe, Y., Takahashi, M., Ito, T., Ishikawa, F., & Miyoshi, T. (2026). The interferon-stimulated gene product HERC5 inhibits human LINE-1 retrotransposition with an ISGylation-independent mechanism. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag334
Vancouver
Nishimori K, Luqman-Fatah A, Watanabe Y, Takahashi M, Ito T, Ishikawa F, et al. The interferon-stimulated gene product HERC5 inhibits human LINE-1 retrotransposition with an ISGylation-independent mechanism. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag334
BibTeX
@article{Nishimori2026,
author = {Nishimori, Kei and Luqman-Fatah, Ahmad and Watanabe, Yuzo and Takahashi, Mari and Ito, Takuhiro and Ishikawa, Fuyuki and Miyoshi, Tomoichiro},
title = {The interferon-stimulated gene product HERC5 inhibits human LINE-1 retrotransposition with an ISGylation-independent mechanism},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag334}
}
EUVIMED